Contact
Please use this form to send email to PR contact of this press release:
Medivation and Astellas Initiate Phase III Trial of Enzalutamide in Patients With Triple-Negative Breast Cancer
TO:
Please use this form to send email to PR contact of this press release:
Medivation and Astellas Initiate Phase III Trial of Enzalutamide in Patients With Triple-Negative Breast Cancer
TO: